FDA label
What is Fasenra used for?
Fasenra contains benralizumab. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Fasenra lists 3 uses: Asthma; Eosinophilic Granulomatosis with Polyangiitis; Hypereosinophilic Syndrome.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Fasenra?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Fasenra, injection, solution
Indications and Usage, quoted from the label by AstraZeneca Pharmaceuticals LP (BLA761070). Cross-references to other label sections are left out.
Asthma
FASENRA is indicated for the add-on maintenance treatment of adult and pediatric patients aged 6 years and older with severe asthma, and with an eosinophilic phenotype.
Limitations of Use:
- FASENRA is not indicated for the relief of acute bronchospasm or status asthmaticus.
Eosinophilic Granulomatosis with Polyangiitis
FASENRA is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).
Hypereosinophilic Syndrome
FASENRA is indicated for the treatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) without an identifiable non-hematologic secondary cause.
Source: DailyMed label, set id da6aca1a-19ed-44a4-abb7-696c7d58b784, version 27, effective May 13, 2026. NDC 0310-1730, one of 3 listings for this product.
Questions
What is Fasenra used for?
The FDA label for Fasenra lists 3 uses: Asthma; Eosinophilic Granulomatosis with Polyangiitis; Hypereosinophilic Syndrome.
What drug class is Fasenra?
FDA lists benralizumab in the Interleukin-5 Receptor alpha-directed Cytolytic Antibody established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Fasenra
- Is Fasenra a controlled substance?Federal schedule
- Is Benralizumab a controlled substance?Federal schedule
- Interleukin-5 Receptor alpha-directed Cytolytic Antibodies listFDA drug class
- Fasenra Medicare Part D coverageBy plan and state
- NDC 0310-1730Fasenra NDC record
- NDC 0310-1745Fasenra NDC record
- NDC 0310-1830Fasenra NDC record